Comprehensive Analysis of RAPGEF2 for Predicting Prognosis and Immunotherapy Response in Patients with Hepatocellular Carcinoma

Figure 1

Expression variation and survival curves of RAPGEF2 genes in hepatocellular carcinoma (HCC). (a) Kaplan-Meier curves for the OS of patients in the different RAPGEF2 expression from TCGA database. (b) The location of copy number variation (CNV) alteration of RAPGEF2 on chromosomes using TCGA datasets. (c) The Kaplan-Meier curves for the OS of patients between the deletion and normal of RAPGEF2 expression from TCGA database. (d) The expression of RAPGEF2 in different tissues.

(a)

(b)

(c)

(d)